Sofinnova Raises €445m To Help European Biotechs Reach Critical Mass - And SPACs Are A Welcome Innovation
Funds To Fuel Maturing Firms
Paris is home to a growing number of biotech companies - but major funding is still hard to come by compared to the US. 
